PharmaCom BioVet, Inc. Begins Nationwide Rollout Of Advanced Veterinary Oncology Centers
Nov 11, 2010
PharmaCom BioVet, Inc. (PINKSHEETS: PHMB) is pleased to announce the company is now beginning the process of locating commercial sites throughout the continental United States to begin the full scale build out of the nation's first branded dedicated Veterinary Oncology Centers.

These centers are going to provide cancer treatment to companion animals using licensed proprietary technologies. PharmaCom BioVet, Inc. expects to garner a significant market share of the overwhelming 41 billion dollar per year veterinary market as the result of early efforts put in by management in seeking out superior treatments and devices.

According to Sharon Berthold, Executive Vice President of PharmaCom BioVet, Inc., "Recent collaborations with world renowned veterinary oncology specialists have allowed us the opportunity to create what I believe are the foremost in companion animal oncology treatments. Recent financial commitments from Investment bankers have allowed us the opportunity to build out our centers on a national scale. We will be concentrating heavily on the branding of PharmaCom BioVet, Inc. using a marketing plan which includes commercials and literature to be distributed to veterinary partners."